Con: Cyclophosphamide for the treatment of lupus nephritis.
about
Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis.An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.
P2860
Con: Cyclophosphamide for the treatment of lupus nephritis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Con: Cyclophosphamide for the treatment of lupus nephritis.
@en
type
label
Con: Cyclophosphamide for the treatment of lupus nephritis.
@en
prefLabel
Con: Cyclophosphamide for the treatment of lupus nephritis.
@en
P2860
P356
P1476
Con: Cyclophosphamide for the treatment of lupus nephritis.
@en
P2093
Chi Chiu Mok
P2860
P304
P356
10.1093/NDT/GFW068
P407
P577
2016-05-14T00:00:00Z